|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 421.00 INR | -0.11% |
|
+10.59% | +35.63% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 369M 322M 296M 276M 524M 532M 3.56B 1.38B 17.26B 1.38B 1.35B 59.46B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 397M 347M 319M 297M 564M 572M 3.83B 1.49B 18.58B 1.49B 1.46B 64.02B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
25.48% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | -0.11% | ||
| 1 week | +10.59% | ||
| Current month | +2.05% | ||
| 1 month | +14.15% | ||
| 3 months | +7.80% | ||
| 6 months | +22.72% | ||
| Current year | +35.63% |
| 1 week | 380 |  | 438.3 |
| 1 month | 363.25 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 91.75 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 30/08/1990 | |
| Director/Board Member | 37 | 05/06/2020 | |
| Director/Board Member | 48 | 29/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.11% | +10.59% | +73.64% | +349.55% | 415M | |
| +0.20% | +1.82% | +13.63% | +83.11% | 48B | |
| +3.36% | +7.06% | +73.53% | +119.26% | 36.89B | |
| +0.42% | +0.67% | -3.09% | +43.33% | 12.37B | |
| +0.31% | +2.02% | +14.54% | +94.52% | 11.95B | |
| +1.55% | +0.58% | +32.90% | +119.07% | 9.01B | |
| +0.66% | +1.66% | +22.21% | +47.39% | 7.2B | |
| +1.22% | +1.60% | +55.46% | -4.13% | 7.05B | |
| +9.99% | +32.94% | -15.50% | +21.82% | 6.58B | |
| +2.57% | +3.67% | +21.87% | +239.23% | 6.55B | |
| Average | +2.01% | +5.01% | +28.92% | +111.32% | 14.6B | |
| Weighted average by Cap. | +1.73% | +3.38% | +30.28% | +91.05% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 74.49M 65.12M 59.85M 55.78M 106M 107M 718M 279M 3.49B 280M 274M 12.01B | 7.83B 82.21M 71.87M 66.05M 61.56M 117M 119M 793M 308M 3.85B 309M 302M 13.26B |
| Net income | 498M 5.23M 4.57M 4.2M 3.92M 7.43M 7.55M 50.47M 19.62M 245M 19.64M 19.22M 844M | 691M 7.26M 6.35M 5.83M 5.44M 10.31M 10.47M 70.03M 27.22M 340M 27.26M 26.67M 1.17B |
| Net Debt | 2.45B 25.7M 22.46M 20.64M 19.24M 36.5M 37.05M 248M 96.34M 1.2B 96.45M 94.38M 4.14B | 2.69B 28.28M 24.72M 22.72M 21.18M 40.17M 40.78M 273M 106M 1.32B 106M 104M 4.56B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 06/07/26 | ₹421.00 | -0.11% | 107,264 |
| 03/07/26 | ₹421.45 | +0.91% | 174,002 |
| 02/07/26 | ₹417.65 | +2.13% | 370,094 |
| 01/07/26 | ₹408.95 | -0.87% | 1,654,483 |
| 30/06/26 | ₹412.55 | +8.37% | 7,823,626 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
